Emodin Improves Lipopolysaccharide-Induced Microcirculatory Disturbance in Rat Mesentery

Objective Sepsis is a systemic inflammatory response syndrome. Emodin is a major ingredient of Rheum Palmatum, a Chinese herb that is widely used in China for treatment of endotoxemia‐related diseases. This study intended to examine the effect of Emodin on LPS‐induced rat mesenteric microcirculatory...

Full description

Saved in:
Bibliographic Details
Published inMicrocirculation (New York, N.Y. 1994) Vol. 20; no. 7; pp. 617 - 628
Main Authors Li, Ang, Dong, Lei, Duan, Mei-Li, Sun, Kai, Liu, Yu-Ying, Wang, Ming-Xia, Deng, Jing-Na, Fan, Jing-Yu, Wang, Bao-En, Han, Jing-Yan
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.10.2013
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective Sepsis is a systemic inflammatory response syndrome. Emodin is a major ingredient of Rheum Palmatum, a Chinese herb that is widely used in China for treatment of endotoxemia‐related diseases. This study intended to examine the effect of Emodin on LPS‐induced rat mesenteric microcirculatory disturbance and the underlying mechanisms. Methods The male Wistar rats received LPS (5 mg/kg/hr) for 90 min, with or without administration of Emodin (10 mg/kg/hr) by enema 30 min before (pre‐treatment) or after (post‐treatment) LPS infusion, and the dynamics of mesenteric microcirculation were determined by inverted intravital microscopy. Expression of adhesion molecules and TLR4, NF‐κB p65, ICAM‐1, MPO, and AP‐1 in mesentery tissue was evaluated by flow cytometry and Western‐blot, respectively. Results Pre or post‐treatment with Emodin significantly ameliorated LPS‐induced leukocyte emigration, reactive oxygen species production and albumin leakage, and the expression of TLR4, NF‐κB p65, ICAM‐1, MPO and AP‐1 in mesentery. Conclusions These results demonstrate the beneficial role of Emodin in attenuating the LPS‐induced microcirculatory disturbance, and support the use of Emodin for patients with endotoxemia.
Bibliography:ark:/67375/WNG-TBDC7HQ1-Q
istex:F60866CAF0C178C6D7E2FB1301D96E658245968A
ArticleID:MICC12061
New Medicine Program of Ministry of Science and Technology of the People's Republic of China - No. 2008ZX09401
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1073-9688
1549-8719
DOI:10.1111/micc.12061